NTSR1 and breast adenocarcinoma: Thus, therapeutic approaches that inhibit expression and function of NTSR1 have proven successful on the human breast adenocarcinoma cell line MDA-MB-231 [17], [20], which has the TNBC phenotype [21], [22].